Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients

por Trang, M., Griffith, D. C., Bhavnani, S. M., Loutit, J. S., Dudley, M. N., Ambrose, P. G., Rubino, C. M.
Publicado 2021

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints

por Bhavnani, S. M., Trang, M., Griffith, D. C., Lomovskaya, O., Hammel, J. P., Loutit, J. S., Cammarata, S. K., Dudley, M. N., Ambrose, P. G., Rubino, C. M.
Publicado 2022